Assort Health vs Marisa.Care
Both put conversational agents in front of patients and they answer different questions with them. Assort builds specialty specific voice agents for the United States provider market, covering scheduling, intake, triage and routing, referrals, refills and document processing, with the specialty tuning as the argument. Marisa is built for Brazil and Mexico and does something structurally different: its agents start from a clinical gap found in the record, an assessment, a prescription, a diagnostic finding, then qualify and navigate the patient toward the care that gap implies, with revenue recapture as the stated outcome. That trigger layer is the more interesting design, and Marisa also publishes a right to request human review of an automated decision, which almost nothing in this index does. For a United States buyer, Assort is the practical answer and Marisa is the better idea.
- It orchestrates three layers rather than answering calls, with agents identifying clinical gaps from assessments, prescriptions and diagnostic findings, then qualifying and navigating patients toward the care those gaps imply.
- The data protection documentation is better than most records in this index, published as policy rather than asserted as compliance, including a stated right to request human review of an automated decision.
- It is built for markets most vendors in this index ignore, with deployments at reference hospitals in Brazil and Mexico under the regimes that actually govern there.
- Specialty specific voice agents rather than a general conversational layer, covering scheduling, intake, triage and routing, referrals, refills and document processing across the patient journey.
- It is deployed and compared across the United States provider market, where the record system integrations, health privacy expectations and staffing economics are the ones most buyers here are working with.
- The specialty tuning is the differentiator: a general agent that mishandles an orthopaedic referral or a dermatology intake creates work rather than removing it.
Side by Side
| Axis | A Assort Health |
M Marisa.Care |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
The jurisdictional difference is the most important thing on this page and it is not a defect on either side: Marisa operates in Brazil and Mexico under those data protection and device regimes, so United States health privacy analysis does not apply to it, and a buyer outside Latin America is evaluating a product built for someone else's rules.
Both run autonomous agents on live patient conversations that book against a real schedule, and neither publishes a confidence threshold, an escalation rate or a bias evaluation. Neither publishes an independent attestation, and neither publishes pricing.